Experience

Our commercially savvy lawyers regularly lead strategic transactions and complex disputes for clients in a variety of industries and regions. We’ve included a small selection of matters for your convenience. Please feel free to contact experience@debevoise.com for a more complete list of matters in any particular category.
Practice
Industry
Region

Debevoise Advises Tribune Media in Its $6.6 Billion Sale to Sinclair

Debevoise & Plimpton LLP is advising Tribune Media Company (NYSE: TRCO) on its $3.9 billion sale to Sinclair Broadcast Group, Inc. (Nasdaq: SBGI) in a transaction valued at nearly $6.6 billion. The transaction has been unanimously approved by the Boards of Directors of both companies and is anticipated to close in the fourth quarter of 2017. Read more >

Debevoise Advises CF Corporation and The Blackstone Group on $1.835 Billion Acquisition of Fidelity & Guaranty Life

Debevoise & Plimpton LLP is advising CF Corporation and The Blackstone Group, one of the world's leading investment firms, on the $1.835 billion all-cash acquisition of Fidelity & Guaranty Life. The transaction is expected to close in the fourth quarter of 2017. Read more >

Debevoise Advises Global Infrastructure Partners on the Formation of a $15.8 Billion Infrastructure Fund

Debevoise & Plimpton LLP has advised Global Infrastructure Partners (GIP), a leading independent global infrastructure investor, in connection with the formation of its latest fund, Global Infrastructure Partners III. The fund successfully closed with $15.8 billion in capital commitments, making it the largest infrastructure fund and one of the largest private investment fund programs ever raised. Read more >

Debevoise Advises Verizon on $3.1 Billion Acquisition of Straight Path Communications

Debevoise & Plimpton LLP is advising Verizon on its acquisition of Straight Path Communications, a leading wireless spectrum holder, in a $3.1 billion all-stock transaction. The transaction has been approved by the boards of directors of both Straight Path and Verizon and is expected to close within nine months. Read more >

Debevoise Advises Helios in FMCG Joint-Venture

The London and Frankfurt offices of Debevoise & Plimpton LLP have advised Helios Investment Partners (“Helios”) in the formation of a joint-venture with GBfoods, creating one of Africa's largest FMCG groups, operating in 30 African countries, including leadership positions in Nigeria and Ghana. Read more >

Debevoise Advises Nornickel on $1 Billion Eurobond Offering

The Moscow and London offices of Debevoise & Plimpton LLP have advised longstanding client PJSC “MMC “Norilsk Nickel” (“Nornickel”) in its $1 billion Eurobond offering due 2023 with a coupon of 4.10% per annum. Read more >

Debevoise Acts Pro Bono for the Center for Reproductive Rights in Securing UN Recommendations to Overturn El Salvador’s Criminalization of Abortion

The London office of Debevoise & Plimpton LLP has advised the Center for Reproductive Rights on a pro bono basis as it secured strong, ground-breaking recommendations from the United Nations Committee on the Elimination of Discrimination Against Women in Geneva (“CEDAW Committee”) to overturn El Salvador’s total criminalization of abortion. Read more >

Debevoise Advises Clayton, Dubilier & Rice on the Formation of a $10 Billion PE Fund

Debevoise & Plimpton LLP has advised Clayton, Dubilier & Rice in connection with the formation of its latest fund, Clayton, Dubilier & Rice Fund X. The fund successfully closed with total capital commitments of $10 billion. CD&R’s Fund X generated strong support from both existing investors, with more than 90% of Fund IX LPs re-committing to Fund X, and a select group of new strategic relationships that resulted in a diverse mix of nearly 200 LPs globally. Read more >

Debevoise Advises Sawai Pharmaceutical in Its $1.05 Billion Acquisition of the Generics Business of Upsher-Smith Laboratories

Debevoise & Plimpton LLP is advising Sawai Pharmaceutical Co. Ltd., a leading Japanese generic pharmaceuticals manufacturer, in its $1.05 billion acquisition of the generic pharmaceuticals business of Upsher-Smith Laboratories, Inc. The transaction is expected to close near the end of June 2017. Read more >

Debevoise Advises Rolls-Royce in Coordinated Resolutions with UK, U.S. and Brazil Investigating Authorities

Debevoise & Plimpton LLP has advised Rolls-Royce plc (Rolls-Royce) in its Deferred Prosecution Agreement (DPA) with the UK’s Serious Fraud Office (SFO), which has been confirmed in open court by the President of the Queen’s Bench Division (Sir Brian Leveson) and published by the SFO. Read more >